Abstract
Hepatocellular carcinoma (HCC) patients commonly experience poor overall survival (OS) and disease-free survival (DFS) after curative surgical resection. Glypican-3 (GPC3) has been suggested as a prognostic biomarker for post-operative survival. However, few to none of these studies have included South Korean patients. This study aimed to determine GPC3 expression rate, clinical correlation, and post-operative prognostic value in South Korean HCC patients who underwent curative surgical resection. Surgically resected tissues from 185 HCC patients were collected and assembled into tissue microarrays (TMAs), which were stained for GPC3 by immunohistochemistry. GPC3 expression rates were correlated with clinicopathological information, and survival analyses were performed to assess the prognostic value of GPC3. GPC3 expression was present in 153 patients (82.7%). GPC3-positive patients were younger with higher frequencies of microvascular invasion and higher AFP levels than GPC3-negative patients. There was no significant difference in survival between GPC3-negative and GPC3-positive patients. Based on multivariate analysis, GPC3 expression was not a prognostic marker for post-operative survival. In South Korean HCC patients, GPC3...Continue Reading
References
Feb 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca Di TommasoMassimo Roncalli
Jun 10, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Nafis ShafizadehSanjay Kakar
Feb 24, 2009·Journal of Hepatology·Luca Di TommasoMassimo Roncalli
Oct 23, 2010·Liver International : Official Journal of the International Association for the Study of the Liver·Kenji YoritaHiroaki Kataoka
Mar 18, 2011·Japanese Journal of Clinical Oncology·Tadatoshi Takayama
Nov 29, 2011·Acta histochemica·Lijie ZhangJie Zheng
Jun 2, 2012·World Journal of Gastroenterology : WJG·Yu-Liang WangZhong-Yang Shen
Jan 12, 2013·The FEBS Journal·Jorge Filmus, Mariana Capurro
Mar 30, 2013·BMC Cancer·Guang-Zhi JinMeng-Chao Wu
Apr 23, 2013·Surgery·Shun-Jun FuLi-Jian Liang
May 21, 2013·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Shuzhe YaoCuijuan Zhang
Jul 23, 2013·British Journal of Cancer·J LiangJ Xu
Feb 6, 2014·PloS One·Li GongWei Zhang
Feb 20, 2014·BMC Cancer·Wei-Kai XiaoLi-Jian Liang
Nov 30, 2014·Medical Oncology·Chenwei PanZhenzhen Pan
Mar 21, 2015·Current Treatment Options in Gastroenterology·Sílvia Vilarinho, Tamar Taddei
Apr 29, 2015·Gut and Liver·UNKNOWN Korean Liver Cancer Study Group (KLCSG), UNKNOWN National Cancer Center, Korea (NCC)
Oct 27, 2015·Rare Tumors·UNKNOWN Rare Cancer Network
Citations
Nov 1, 2016·Bioscience Trends·Min YaoDengfu Yao
Jun 18, 2017·Medicinal Research Reviews·Fubo ZhouJie Tian
Jan 15, 2017·Journal of Gastroenterology and Hepatology·Ran XueXiaodan Jing
Jan 26, 2018·Medicine·Hong LiuYong Zeng
Jun 11, 2019·Virusdisease·Bita MoudiHamidreza Mahmoudzadeh-Sagheb
Jun 15, 2018·Medicine·Jian ZhangXin Li
Jul 10, 2019·Disease Markers·Tao HuangWei-Jun Fan
Apr 28, 2021·BMC Cancer·Jian-Yao WangTao Peng